Polar NanoPharma utilizes Ecostratar Technology to create water-based polycarbamate-polyurea nanocapsules that enable targeted drug delivery directly to tumor sites, facilitating intracellular release of therapeutic agents. This approach enhances treatment efficacy while minimizing the systemic toxicity and side effects commonly associated with conventional chemotherapy.
Funding
Funding not disclosed
Founders
Product
Problem
Conventional cancer treatments often lack precision, leading to systemic toxicity and harmful side effects as therapeutic agents affect both cancerous and healthy cells. Effective drug delivery to tumor sites and intracellular release within cancer cells remains a significant challenge.
Solution
Polar NanoPharma offers Ecostratar Technology, a nanotechnology platform for creating water-based polycarbamate-polyurea nanocapsules designed for targeted drug delivery in oncology. The nanocapsules facilitate the encapsulation of a broad range of molecules, including small molecules, metal complexes, peptides, proteins, and gene therapies, without requiring chemical modification. These nanocapsules are engineered to enhance accumulation and internalization in response to local pH changes, creating an ideal system for targeting tumor lesions and ensuring intracellular release within cancer cells. The platform's water-based, one-pot synthetic method promotes a clean and scalable production process, enhancing drug biodistribution while reducing systemic drug-related toxicity and side effects.
Target Audience
Polar NanoPharma's primary target audience includes pharmaceutical companies and oncology researchers focused on developing more effective and less toxic cancer therapies.
Features
- Water-based polycarbamate-polyurea nanocapsules for targeted drug delivery
- Ecostratar Technology enables the creation of robust and multifunctional nanocapsules
- One-pot synthetic method for efficient and scalable production
- Designed to prevent early drug degradation and leakage during circulation
- Biocompatible and biodegradable polymers enhance drug biodistribution and reduce systemic toxicity
- Nanoparticles capable of encapsulating a broad range of molecules with diverse physicochemical properties
- Engineered nanoparticles enhance accumulation and internalization in response to local pH changes
- Polymers in nanoparticle shells enable targeted drug delivery with biodegradable groups for controlled release in cancerous cells